Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting (Q33228392)

24 July 2017

title

Inhibition of papillomavirus protein function in cervical cancer cells by intrabody targeting (English)

1 reference

24 July 2017

main subject

cervix uterine cancer

1 reference

Michael Coleman

0 references

Greg Winter

0 references

John Doorbar

object named as

John Doorbar

1 reference

24 July 2017

Heather Griffin

1 reference

24 July 2017

Robert Elston

1 reference

24 July 2017

Deborah Jackson

1 reference

24 July 2017

Keith Ansell

1 reference

24 July 2017

Greg Winter

1 reference

24 July 2017

language of work or name

English

0 references

publication date

14 November 2005

1 reference

Journal of Molecular Biology

24 July 2017

1 reference

inferred from page(s)

published in

1 reference

24 July 2017

volume

355

1 reference

24 July 2017

1 reference

24 July 2017

page(s)

360-378

1 reference

Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria

24 July 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Therapy for genital human papillomavirus-related disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Apoptosis detection: an overview

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Perspectives on the neutralization of interferons by antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Kinetic selection of HPV 16 E6/E7-directed antisense nucleic acids: anti-proliferative effects on HPV 16-transformed cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Intracellular antibodies and challenges facing their use as therapeutic agents

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Targeted tumor killing via an intracellular antibody against erbB-2.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Binding of human papillomavirus 16 E6 to p53 and E6AP is impaired by monoclonal antibodies directed against the second zinc-binding domain of E6

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The selection of intracellular antibodies.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Activation of p53 in cervical carcinoma cells by small molecules.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Studies on a New Human Cell Line (SiHa) Derived from Carcinoma of Uterus. I. Its Establishment and Morphology

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Difficulties and pitfalls in analysis of apoptosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Biotechnological approaches to the production of idiotypic vaccines and antiidiotypic antibiotics.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Making antibody fragments using phage display libraries

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

High efficiency transformation of E. coli by high voltage electroporation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Antibody arrays for high-throughput screening of antibody-antigen interactions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Apoptotic detection methods--from morphology to gene

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Characterization of Events during the Late Stages of HPV16 Infectionin VivoUsing High-Affinity Synthetic Fabs to E4

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Human papillomavirus type 16 E6 increases the degradation rate of p53 in human keratinocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Novel selection method for engineered antibodies using the mechanism of Fv fragment stabilization in the presence of antigen.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Methods for generating multivalent and bispecific antibody fragments

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The role of E6AP in the regulation of p53 protein levels in human papillomavirus (HPV)-positive and HPV-negative cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Crystal structure of a diabody, a bivalent antibody fragment

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Unique features of the pre-T-cell receptor alpha-chain: not just a surrogate

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Filamentous growth of Escherichia coli K12 elicited by dimeric, mixed-valence complexes of ruthenium

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Defining the Protective Antibody Response for HIV-1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Mechanisms of human papillomavirus-induced oncogenesis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Proteolytic selection for protein folding using filamentous bacteriophages

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The identification of a conserved binding motif within human papillomavirus type 16 E6 binding peptides, E6AP and E6BP

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Characterization of a new intrabody directed against the N-terminal region of human p53.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The 2.0-A resolution crystal structure of a trimeric antibody fragment with noncognate VH-VL domain pairs shows a rearrangement of VH CDR3

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Functional inactivation of the conserved Sem1p in yeast by intrabodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Expression of the HPV E7 oncoprotein mimics but does not evoke a p53-dependent cellular DNA damage response pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Identification of human papillomavirus type 18 E6 polypeptide in cells derived from human cervical carcinomas

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

HPV E6 antisense induces apoptosis in CaSki cells via suppression of E6 splicing

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

The E1E4 protein of human papillomavirus type 16 associates with a putative RNA helicase through sequences in its C terminus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Human autoimmune anti-proteinase 3 scFv from a phage display library

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Diabodies: small bispecific antibody fragments

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

RU486 increases radiosensitivity and restores apoptosis through modulation of HPV E6/E7 in dexamethasone-treated cervical carcinoma cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.10.077

Identifiers

DOI

10.1016/J.JMB.2005.10.077

1 reference

24 July 2017

1 reference